DNLIDenali Therapeutics Inc.
24.92USD-3.00%Mkt Cap: 3.98B $P/E: —3d ago
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases. The company develops Eclitasertib (SAR443122/DNL758) RIPK1 inhibitor p…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap3.98B $
Enterprise Value3.32B $
Revenue (TTM)3.60M $
Gross Profit-397.21M $
Net Income (TTM)-512.54M $
Revenue/Share0.0200 USD
Last Price24.92 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees503
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS24823R1059
Valuation
P/E (Trailing)—
P/E (Forward)-10.28
PEG—
EV/EBITDA-6.30
EV/Revenue919.92
P/S1106.60
P/B4.77
EPS (TTM)-2.76
EPS (Forward)-2.43
52W Range
12.5884% of range27.30
52W High27.30 USD
52W Low12.58 USD
Profitability
Gross Margin0.00%
Oper. Margin-3601.30%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-50.56%
ROA-44.77%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-412.60M $
CapEx (TTM)9.50M $
FCF Margin-7450.83%
FCF Yield-6.74%
Net Debt-672.78M $
Net Debt/EBITDA1.28
Balance Sheet
Debt/Equity0.04
Current Ratio8.37
Quick Ratio7.95
Book Value/Sh5.228 USD
Cash/Share4.445 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)35.44 USD
Upside (mean)+42.2%
Target Range27.00 USD – 42.00 USD
$27.00+42.2% to mean$42.00
# Analysts16
Ownership
Shares Out.159.85M
Float155.08M
Insiders9.09%
Institutions101.34%
Short Interest
Short Ratio10.3d
Short % Float11.51%
Short % Out.10.91%
Shares Short17.43M
Short (prev mo.)15.95M
Technical
SMA 5024.24 (+2.8%)
SMA 20020.42 (+22.1%)
Beta1.00
S&P 52W Chg18.16%
Avg Vol (30d)1.56M
Avg Vol (10d)1.24M
Technical Indicators
RSI (14)54.2
MACD0.3481
MACD Signal0.2991
MACD Hist.+0.0490
BB Upper25.79 USD
BB Middle24.29 USD
BB Lower22.79 USD
BB Width12.32%
ATR (14)1.017 USD
Vol Ratio (20d)0.50x